Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Select Medical Holdings (SEM) over the last 16 years, with Q3 2025 value amounting to -$83.1 million.

  • Select Medical Holdings' Change in Receivables fell 27204.22% to -$83.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.4 million, marking a year-over-year decrease of 11281.54%. This contributed to the annual value of $95.8 million for FY2024, which is 839109.0% up from last year.
  • Select Medical Holdings' Change in Receivables amounted to -$83.1 million in Q3 2025, which was down 27204.22% from $548000.0 recorded in Q2 2025.
  • Select Medical Holdings' 5-year Change in Receivables high stood at $195.3 million for Q1 2024, and its period low was -$83.1 million during Q3 2025.
  • Moreover, its 5-year median value for Change in Receivables was -$19.8 million (2022), whereas its average is $6.9 million.
  • Examining YoY changes over the last 5 years, Select Medical Holdings' Change in Receivables showed a top increase of 25256.06% in 2024 and a maximum decrease of 40158.27% in 2024.
  • Quarter analysis of 5 years shows Select Medical Holdings' Change in Receivables stood at -$22.5 million in 2021, then soared by 244.71% to $32.5 million in 2022, then crashed by 112.83% to -$4.2 million in 2023, then crashed by 401.58% to -$20.9 million in 2024, then crashed by 297.51% to -$83.1 million in 2025.
  • Its last three reported values are -$83.1 million in Q3 2025, $548000.0 for Q2 2025, and $89.1 million during Q1 2025.